Company Filing History:
Years Active: 2002-2003
Title: Innovations by Anne H Fortier
Introduction
Anne H Fortier is a notable inventor based in Rockville, MD (US). She has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment and angiogenesis regulation. With a total of 2 patents, her work has the potential to impact various medical conditions.
Latest Patents
Fortier's latest patents focus on compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markers. These compositions include kallikreins such as prostate-specific antigen (PSA) and serine protease homologs. The research highlights the potent antiangiogenic activity of these markers on human and animal cells, especially endothelial cells. The patents suggest that PSA, its homologs, and inhibitory fragments can be combined with pharmaceutically acceptable excipients or carriers to inhibit angiogenesis and related diseases, including cancer, arthritis, macular degeneration, and diabetic retinopathy.
Career Highlights
Anne H Fortier is associated with Entremed, Inc., where she continues to advance her research and innovations. Her work is crucial in developing therapeutic strategies that target angiogenesis, a process that plays a significant role in tumor growth and metastasis.
Collaborations
One of her notable collaborators is John W Holaday, with whom she has worked on various projects related to her patents and research initiatives.
Conclusion
Anne H Fortier's contributions to the field of biomedical research through her patents and collaborations demonstrate her commitment to advancing medical science. Her innovative approaches to regulating angiogenesis could lead to significant breakthroughs in treating various diseases.